TARA HENDRIX: Open Payments
NPI 1467505958 · LEXINGTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 33 payments from 12 companies in 2025. Trend: 2023 $336 · 2024 $657 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $168 |
| AstraZeneca Pharmaceuticals LP | 5 | $156 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Novo Nordisk Inc | 4 | $78 |
| Verona Pharma, Inc. | 2 | $63 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| Abbott Laboratories | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $21 |
Products named: JARDIANCE, FARXIGA, Ohtuvayre, BREZTRI, Ozempic, AREXVY, Rybelsus, SHINGRIX.
Industry payments across TN — which companies pay providers there.
